Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Phase III results with Lilly's raloxifene reported

June 6, 1997

No Comments

r-metHuSCF + filgrastrim for PBPC mobilization and transplantation: a phase I/II trial

June 6, 1997

No Comments

Fujisawa discloses agents for bone metabolism disorders

June 6, 1997

No Comments

Didronel PMO approved for prevention of osteoporosis in U.K.

June 5, 1997

No Comments

Cholesterol-lowering activity of squalene synthase inhibitor in animal models

June 5, 1997

No Comments

Focus on drug interactions with a common food: grapefruit

June 5, 1997

No Comments

Shaman issued U.S. patents for type II diabetes compounds

June 4, 1997

No Comments

U. of California discloses mammalian EPO-BP

June 4, 1997

No Comments

ACE inhibitors inhibit bone resorption in vitro

June 3, 1997

No Comments

AGE inhibitor described by Kissei

June 3, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

Phase III results with Lilly's raloxifene reported

r-metHuSCF + filgrastrim for PBPC mobilization and transplantation: a phase I/II trial

Fujisawa discloses agents for bone metabolism disorders

Didronel PMO approved for prevention of osteoporosis in U.K.

Cholesterol-lowering activity of squalene synthase inhibitor in animal models

Focus on drug interactions with a common food: grapefruit

Shaman issued U.S. patents for type II diabetes compounds

U. of California discloses mammalian EPO-BP

ACE inhibitors inhibit bone resorption in vitro

AGE inhibitor described by Kissei

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Endocrine/metabolic RSS

Endocrine/metabolic
RSS